Our academic collaborators’ seminal contributions push the field forward
Our constellation of renowned thinkers and partners
The right collaborators across pharma, biotech and nonprofit
The next generation of scientific leaders in cancer immunotherapy
Stories & Announcements
PICI in the News
Resources for Press
Funding the Future of Cancer Research: The Parker Institute for Cancer Immunotherapy Awards Nearly $3 Million to Six Early Career Researchers
Improving Conventional Wisdom: From CAR-T Therapy to Diversity in STEM, Avery Posey Has Big Ideas
Ute Dugan Joins the Parker Institute for Cancer Immunotherapy as Senior Vice President of Clinical Research
Develop breakthrough immune therapies to turn all cancers into curable diseases faster
The driving force behind PICI’s research and operations
Transformative science requires visionary philanthropy
Join us. Change lives.
Our research team aims to answer immunotherapy’s most fundamental questions. What happens to the immune system when a patient gets cancer? How can we make immunotherapy kill all types of tumors so more patients can live a cancer-free life? We work with the best in academia and industry to find answers, fast. And we’re building an arsenal of new tools – from cancer vaccines to next-gen cell therapies – so we can end cancer. For good.
PICI-Supported research projects
John Connolly, PhD
Chief Scientific Officer
Lisa Butterfield, PhD
Vice President, PICI Research Center
Samantha Bucktrout, PhD
Sara Marr, MS
Senior Program Manager Research
Theresa LaVallee, PhD
Vice President, Translational Medicine and Regulatory Affairs
Nikesh Kotecha, PhD
Vice President, Informatics
Pier Federico Gherardini, PhD
Lacey Kitch, PhD
Christine (Chris) Spencer, PhD
Senior Research Scientist
Cheryl Selinsky, PhD
Vice President, Research Operations
Associate Director, Biospecimen Operations
A first-of-its-kind data analysis engine for scientific discovery.
Can we outsmart cancer by learning from the past?
A data-driven approach to metastatic triple negative breast cancer
Tackling one of the toughest disease sites to unlock the promise of cell and gene therapy in solid tumors
Can we predict and prevent autoimmune disease?
Improving cancer vaccines and cell therapies for patients through AI.